Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 5
2008 1
2009 3
2010 2
2011 3
2012 3
2013 1
2014 2
2015 1
2016 1
2017 3
2018 1
2019 1
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Rapid cGMP manufacturing of COVID-19 monoclonal antibody using stable CHO cell pools.
Agostinetto R, Rossi M, Dawson J, Lim A, Simoneau MH, Boucher C, Valldorf B, Ross-Gillespie A, Jardine JG, Sok D, Burton DR, Hassell T, Broly H, Palinsky W, Dupraz P, Feinberg M, Dey AK. Agostinetto R, et al. Among authors: dey ak. Biotechnol Bioeng. 2022 Feb;119(2):663-666. doi: 10.1002/bit.27995. Epub 2021 Dec 10. Biotechnol Bioeng. 2022. PMID: 34796474 Free PMC article.
Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models.
Lelis F, Byk LA, Pustylnikov S, Nguyen V, Nguyen B, Nitz M, Tarte P, Tungare K, Li J, Manna S, Maiti S, Mehta DH, Sekar N, Posadas DM, Dhamankar H, Hughes JA, Aulisa L, Khan A, Melo MB, Dey AK. Lelis F, et al. Among authors: dey ak. Sci Rep. 2023 Dec 1;13(1):21172. doi: 10.1038/s41598-023-46233-6. Sci Rep. 2023. PMID: 38040905 Free PMC article.
A cationic nanoemulsion for the delivery of next-generation RNA vaccines.
Brito LA, Chan M, Shaw CA, Hekele A, Carsillo T, Schaefer M, Archer J, Seubert A, Otten GR, Beard CW, Dey AK, Lilja A, Valiante NM, Mason PW, Mandl CW, Barnett SW, Dormitzer PR, Ulmer JB, Singh M, O'Hagan DT, Geall AJ. Brito LA, et al. Among authors: dey ak. Mol Ther. 2014 Dec;22(12):2118-2129. doi: 10.1038/mt.2014.133. Epub 2014 Jul 16. Mol Ther. 2014. PMID: 25027661 Free PMC article.
The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection.
Charles TP, Burton SL, Arunachalam PS, Cottrell CA, Sewall LM, Bollimpelli VS, Gangadhara S, Dey AK, Ward AB, Shaw GM, Hunter E, Amara RR, Pulendran B, van Gils MJ, Derdeyn CA. Charles TP, et al. Among authors: dey ak. PLoS Pathog. 2021 Feb 8;17(2):e1009257. doi: 10.1371/journal.ppat.1009257. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33556148 Free PMC article.
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate.
Dey AK, Cupo A, Ozorowski G, Sharma VK, Behrens AJ, Go EP, Ketas TJ, Yasmeen A, Klasse PJ, Sayeed E, Desaire H, Crispin M, Wilson IA, Sanders RW, Hassell T, Ward AB, Moore JP. Dey AK, et al. Biotechnol Bioeng. 2018 Apr;115(4):885-899. doi: 10.1002/bit.26498. Epub 2017 Dec 11. Biotechnol Bioeng. 2018. PMID: 29150937 Free PMC article.
Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens.
Whitaker N, Hickey JM, Kaur K, Xiong J, Sawant N, Cupo A, Lee WH, Ozorowski G, Medina-Ramírez M, Ward AB, Sanders RW, Moore JP, Joshi SB, Volkin DB, Dey AK. Whitaker N, et al. Among authors: dey ak. J Pharm Sci. 2019 Jul;108(7):2264-2277. doi: 10.1016/j.xphs.2019.01.033. Epub 2019 Feb 15. J Pharm Sci. 2019. PMID: 30776383 Free PMC article.
34 results